This systematic review protocol was developed using relevant guidelines, including the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Protocols (PRISMA-P). A search of five databases, namely CINAHL (EBSCOhost), EMBASE (OvidSP), Global Health (OvidSP), MEDLINE (OvidSP), and Scopus ( www.scopus.com ), and gray literature resources will be conducted. Two independent reviewers will screen and select studies, assess their quality using the \"Mixed Methods Appraisal Tool,\" and extract data from eligible studies. Publications or articles are eligible if they report implementation strategies, facilitators, or barriers to scaling up/sustainability of task-sharing in FP/contraception or the outcomes of the scale-up/sustainability interventions. A convergent synthesis that integrates qualitative, quantitative, descriptive, and mixed-methods data into one dataset will be used for analysis based on an a priori framework-the Cochrane Effective Practice and Organization of Care (EPOC) taxonomy of the health system framework. Two independent reviewers will assess the quality of evidence using the GRADE-CERQual guideline.
To our knowledge, this systematic review of implementation strategies, facilitators, and barriers to scaling up and sustaining task-sharing in family planning is the first in this area. Our rigorous methodology based on up-to-date guidelines can help generate relevant recommendations to support interventions to scale up and sustain task-sharing in family planning.
PROSPERO CRD42022339885.
方法:本系统综述方案是使用相关指南制定的,包括系统评价和荟萃分析(PRISMA)方案(PRISMA-P)的首选报告项目。搜索五个数据库,namelyCINAHL(EBSCOhost),EMBASE(OvidSP),全球卫生(OvidSP),MEDLINE(OvidSP),和Scopus(www.scopus.com),将进行灰色文献资源。两名独立的审稿人将筛选和选择研究,使用“混合方法评估工具”评估其质量,并从符合条件的研究中提取数据。出版物或文章如果报告实施战略,则符合资格,主持人,或FP/避孕中任务分担的扩大/可持续性障碍或扩大/可持续性干预措施的结果。一种融合定性、定量,描述性,描述性和混合方法数据到一个数据集中将用于基于先验框架的分析-卫生系统框架的Cochrane有效实践和护理组织(EPOC)分类法。两名独立评审员将使用GRADE-CERQual指南评估证据质量。
结论:据我们所知,对实施战略的系统审查,主持人,扩大和维持计划生育任务分担的障碍是这一领域的首要问题。我们基于最新指南的严格方法可以帮助生成相关建议,以支持干预措施,以扩大和维持计划生育中的任务分担。
背景:PROSPEROCRD42022339885。